C1QTNF9 and fibrosis: Furthermore, cardiac‐specific overexpression of CTRP9 decreased cardiomyocyte size, cardiac fibrosis, and the cardiac contents of α‐SMA, TGF‐β, and β‐MHC in mice with established MI (Figure 4G–I).